Article
GGCn polymorphism of eRF3a/GSPT1 gene and breast cancer susceptibility.
Medical oncology (Northwood, London, England) - 1 Sept 2012
Miri Mahboobe, Hemati Simin, Safari Foruzan, Tavassoli Manoochehr
Abstract excerpt
The significance of translation regulatory factors in elevating the risk of cancer has been recently recognized. Eukaryotic release factor 3a (eRF3a) is a translation termination protein that is encoded by G1 to S phase transition 1 gene (GSPT1). The eRF3a/GSPT1 exon 1 contains a trinucleotide GGC repeat coding for a polyglycine expansion in the N-terminal of the protein. In the present study, we determined the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
